{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:14:51Z","timestamp":1793060091339,"version":"4.5.0"},"reference-count":75,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Drug ototoxicity limits the quality of life of patients after treatment, having serious consequences, especially for psychosocial development of children. Although the ototoxicity of many drugs resolves after treatment discontinuation, the use of platinum derivatives and aminoglycosides is associated with permanent hearing loss. In this review, we have listed ototoxic drugs and the mechanisms by which they damage the ears. Moreover, possible protective strategies and important methods for early detection of ototoxic effects are discussed.<\/jats:p>","DOI":"10.1002\/cpt.603","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T21:44:39Z","timestamp":1482356679000},"page":"491-500","source":"Crossref","is-referenced-by-count":245,"title":["Drug\u2010induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies"],"prefix":"10.1111","volume":"101","author":[{"given":"C","family":"Lanvers\u2010Kaminsky","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology and Oncology University Children's Hospital of Muenster Muenster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AG am","family":"Zehnhoff\u2010Dinnesen","sequence":"additional","affiliation":[{"name":"Department of Phoniatrics and Pedaudiology University Hospital of Muenster Muenster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Parfitt","sequence":"additional","affiliation":[{"name":"Department of Phoniatrics and Pedaudiology University Hospital of Muenster Muenster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Ciarimboli","sequence":"additional","affiliation":[{"name":"Experimental Nephrology Department of Internal Medicine D, University Hospital of Muenster Muenster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"e_1_2_4_1_1","volume-title":"Ototoxicity","author":"Roland P.S.","year":"2004"},{"key":"e_1_2_4_2_1","first-page":"601","article-title":"Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide","volume":"15","author":"Cianfrone G.","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2011.05.008"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03259891"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2013.05.006"},{"key":"e_1_2_4_6_1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0030-6665(20)30770-2","article-title":"Ototoxicity of loop diuretics","volume":"26","author":"Rybak L.P.","year":"1993","journal-title":"Otolaryngol. Clin. North Am."},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(00)00027-7"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2007.06.021"},{"key":"e_1_2_4_9_1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0030-6665(20)30768-4","article-title":"Ototoxic liability of erythromycin and analogues","volume":"26","author":"Brummett R.E.","year":"1993","journal-title":"Otolaryngol. Clin. North Am."},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5955(97)00009-9"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-6665(20)30767-2"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ar.22578"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300103162"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.5355"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.130.5.556"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60142-7"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-6665(05)70229-2"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00018.2009"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00044.2006"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2005.07.053"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-2976-z"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1691"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn418"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.109.063172"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090610"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500455"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.1110"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2011.10.020"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(83)90398-X"},{"key":"e_1_2_4_30_1","first-page":"CD010885","article-title":"Different infusion durations for preventing platinum\u2010induced hearing loss in children with cancer","volume":"6","author":"As J.W.","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/000164800750061624"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.022244"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2006.09.015"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1037"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1218(97)00037-2"},{"key":"e_1_2_4_36_1","unstructured":"Hain T.C.Pharmacodynamics of gentamicin as they relate to ototoxicity. <http:\/\/www.dizziness\u2010and\u2010balance.com\/disorders\/bilat\/PCD.html>."},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.9.1383"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2011.02452.x"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112463"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054794"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.05.018"},{"key":"e_1_2_4_42_1","first-page":"299","article-title":"Cellular uptake of aminoglycosides","volume":"105","author":"Steyger P.S.","year":"2005","journal-title":"Volta Rev."},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.3109\/00206098809081584"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0793-289"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5955(98)00200-7"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx0496946"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.655092"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.1.38"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0806397"},{"key":"e_1_2_4_50_1","article-title":"Concentration\u2010response relationship of hearing impairment caused by quinine and salicylate: pharmacological similarities but different molecular mechanisms","author":"Alvan G.","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2012.11.016"},{"key":"e_1_2_4_52_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022347"},{"key":"e_1_2_4_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-144"},{"key":"e_1_2_4_54_1","first-page":"46","article-title":"Quinine reduces the dynamic range of the human auditory system","volume":"118","author":"Berninger E.","year":"1998","journal-title":"Acta Otolaryngol."},{"key":"e_1_2_4_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/9713"},{"key":"e_1_2_4_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.958"},{"key":"e_1_2_4_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348940010900416"},{"key":"e_1_2_4_58_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016489609137891"},{"key":"e_1_2_4_59_1","first-page":"388","article-title":"Psychiatric complications with erythromycin","volume":"15","author":"Cohen I.J.","year":"1981","journal-title":"Drug Intell. Clin. Pharm."},{"key":"e_1_2_4_60_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.6.791"},{"key":"e_1_2_4_61_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01088-08"},{"key":"e_1_2_4_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/019459989811800420"},{"key":"e_1_2_4_63_1","unstructured":"American Academy of Audiology.Ototoxicity Monitoring. Position Statement and Clinical Practice Guidelines. <http:\/\/audiology\u2010web.s3.amazonaws.com\/migrated\/OtoMonGuidelines.pdf_539974c40999c1.58842217.pdf>."},{"key":"e_1_2_4_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24236"},{"key":"e_1_2_4_65_1","volume-title":"Paediatric Behavioural Audiometry (0 \u2013 6 Years)","author":"Kerkhofs K.","year":"2016"},{"key":"e_1_2_4_66_1","volume-title":"Ototoxicity in Children","author":"am Zehnhoff\u2010Dinnesen A.","year":"2016"},{"key":"e_1_2_4_67_1","doi-asserted-by":"publisher","DOI":"10.1121\/1.3531934"},{"key":"e_1_2_4_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950190415"},{"key":"e_1_2_4_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.4228"},{"key":"e_1_2_4_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00106-005-1368-1"},{"key":"e_1_2_4_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24307"},{"key":"e_1_2_4_72_1","article-title":"Platinum\u2010induced ototoxicity: a review of prevailing ototoxicity criteria","author":"Waissbluth S.","year":"2016","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"e_1_2_4_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690404"},{"key":"e_1_2_4_74_1","first-page":"CD009219","article-title":"Medical interventions for the prevention of platinum\u2010induced hearing loss in children with cancer","volume":"7","author":"As J.W.","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2006.04.011"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.603","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:34:58Z","timestamp":1699364098000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1002\/cpt.603"],"URL":"https:\/\/doi.org\/10.1002\/cpt.603","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]}}}